Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by Wolfe Research to “Peer Perform”
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by equities research analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating in a research note issued to investors on Wednesday, MarketBeat reports. Several other equities research analysts have also commented on VRTX. Truist Financial boosted their price objective on shares of […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by equities research analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating in a research note issued to investors on Wednesday, MarketBeat reports. Several other equities research analysts have also commented on VRTX. Truist Financial boosted their price objective on shares of […]
